| Literature DB >> 30227444 |
Saulius Sadauskas1, Albinas Naudžiūnas1, Alvydas Unikauskas1, Edita Mašanauskienė1, Andrius Ališauskas1, Giedrė Bakšytė2, Andrius Macas3.
Abstract
BACKGROUND This study aimed at evaluating the diagnostic and outcome prediction value of transthoracic impedance cardiography (ICG) in heart failure (HF) patients admitted for in-hospital treatment due to flare-ups of their condition. MATERIAL AND METHODS In total, 120 patients of intensive care units who were admitted due to HF flare-ups were involved to the study. The findings of ICG were compared to data obtained by other methods used for diagnosing HF. RESULTS Statistically significant (p<0.001) results were obtained when evaluating differences in ICG data between admission and discharge from the intensive care unit. In addition, a correlation was detected between brain natriuretic peptide (BNP) and thoracic fluid content index (r=0.4, p<0.001). Differences in ICG values, and BNP data emerged after the participants were grouped according to NYHA classes (p<0.05). The evaluation of lethal outcome during 6 months after the discharge yielded statistically significant results: BNP ≥350 pg/mL (Odds Ratio (OR) 4.4), thoracic fluid content ≥34 1/kOhm (OR 4.3), and systolic time ratio ≥0.55 (OR 2.9), p<0.05. CONCLUSIONS ICG data might be applied for the diagnosis and prognosis of HF, although the links between ICG and HF need further evaluation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30227444 PMCID: PMC6157086 DOI: 10.12659/MSM.910754
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Characteristics of the studied population.
| Parameters | Mean ±95% Cl |
|---|---|
| Sex (M/F) | 60/60 |
| Age (years) | 68.9±2.2 |
| Systolic blood pressure (mmHg) | 126.3±3.6 |
| Diastolic blood pressure (mmHg) | 77.8±3.6 |
| Respiratory rate (breaths/minute) | 27.3±0.9 |
| Heart Failure NYHA class | 3.3±0.1 |
| Intravenous dose of diuretics (mg/day) | 98.5±4.8 |
| Coronary artery disease (relevant diagnosis) | 86.0 |
| Arterial hypertension (relevant diagnosis) | 68.7 |
| Cardiomyopathy (relevant diagnosis) | 91.0 |
| Chest X-ray: pulmonary congestion/edema | 92.3 |
Results of differences in ICG data between admission to and discharge from the intensive care unit evaluated by using the Wilcoxon signed ranks test.
| ICG parameter | Admission (intensive care unit) mean (95% Cl) | Discharge (intensive care unit) mean (95% Cl) | Wilcoxon test p-value |
|---|---|---|---|
| TFC (1/kOhm) | 47.5 (44.6–50.4) | 43.8 (41.0–46.6) | <0.001 |
| TFCI (1/kOhm/m2) | 25.2 (23.4–27.0) | 23.4 (21.6–25.2) | <0.001 |
| SI (mL/m2) | 30.9 (28.7–33.1) | 33.9 (31.8–36.0) | <0.001 |
| CO (L/min) | 5.0 (4.7–5.3) | 5.3 (5.0–5.6) | <0.001 |
| STR | 0.43 (0.38–0.48) | 0.35 (0.32–0.38) | <0.001 |
| LCW (kg*m) | 6.0 (5.6–6.4) | 6.3 (5.9–6.7) | <0.001 |
| LCWI (kg*m/m2) | 3.1 (2.9–3.3) | 3.2 (3.0–3.4) | <0.001 |
Correlation of BNP and ICG data.
| ICG parameter | Spearman’s r | p-Value |
|---|---|---|
| TFC | 0.32 | <0.001 |
| TFCI | 0.4 | <0.001 |
| SI | −0.15 | 0.093 |
| CO | −0.23 | 0.012 |
| STR | 0.18 | 0.05 |
| LCW | −0.29 | 0.002 |
| LCWI | −0.25 | 0.006 |
Relationship of ICG and other parameters with lethal outcome.
| Parameter | Odds ratio (95% Cl) | Mantel-Haenszel common odds ratio estimate p-value | Log-rank test p-value |
|---|---|---|---|
| Sex (Men) | 2.1 (0.9–5.1) | 0.09 | 0.105 |
| NYHA class III–IV | 2.5 (0.5–11.8) | 0.24 | 0.241 |
| BNP ≥350 pg/ml | 4.4 (1.3–15.7) | 0.02 | 0.017 |
| TFC ≥34 1/kOhm | 4.3 (1.0–19.7) | 0.05 | 0.049 |
| TFCI ≥18 1/kOhm/m2 | 2.8 (0.9–8.7) | 0.08 | 0.078 |
| SI ≤40 mL/m2) | 0.8 (0.3–2.4) | 0.73 | 0.758 |
| CO ≤3.0 L/min) | 1.1 (0.3–3.8) | 0.87 | 0.765 |
| STR ≥0.55 | 2.9 (1.1–7.7) | 0.04 | 0.05 |
| LCWI ≤3.0 kg*m/m2 | 0.9 (0.4–2.1) | 0.81 | 0.93 |
Figure 1Kaplan-Meier 6-month survival curve according to the serum BNP concentration.
Figure 2Kaplan-Meier 6-month survival curve according to the TFC ICG data.
Figure 3Kaplan-Meier 6-month survival curve according to the STR ICG data.